Second-Quarter Results Beat Estimates for America's Largest For-Profit Hospital Operator

Deep News
07/24

Hca Healthcare Inc (NYSE: HCA) reported second fiscal quarter results that surpassed market expectations for both revenue and profit, though the company simultaneously reduced its full-year earnings guidance, primarily due to an approximate $4 billion pretax profit impact from changes in patient payment structures.

For the quarter ending June 30, the company's revenue reached $20.23 billion, an 8.7% increase year-over-year and exceeding analyst forecasts of $19.76 billion. Net income attributable to the company stood at $1.699 billion, or $7.62 per diluted share, up 11.6% from the prior year and above the consensus estimate of $7.46 per share. Adjusted EBITDA was $4.027 billion, a 4.6% increase from the same period last year.

In terms of operational metrics, same-facility inpatient admissions grew by 2.5% and emergency department visits rose by 3.6%, but inpatient surgeries declined by 2.3% and outpatient surgeries fell by 3.4%. Management noted that patients are opting for emergency care over elective procedures, reflecting a shift in consumer behavior.

The company faces headwinds from a worsening patient payment mix. Following the expiration of federal health insurance subsidies, more patients lost coverage, leading to a higher proportion of uninsured patients. This resulted in a roughly $400 million pretax profit loss for the quarter. This impact was partially offset by approximately $400 million in incremental gains from a Florida Medicaid supplemental payment program.

Management revised its full-year guidance downward, now forecasting earnings per share between $28.70 and $30.50, compared to the previous range of $29.10 to $31.50. Revenue expectations were narrowed to a range of $77 billion to $79.5 billion. The adjusted EBITDA forecast was lowered to between $15.4 billion and $16.1 billion.

Although quarterly results exceeded expectations and the company's valuation metrics still appear reasonable, the downward revision to full-year guidance has made investors cautious about the persistent effects of changes in payment structures.

A wide range of information and precise analysis are available on the Sina Finance app.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10